Navigation Links
Oncolytics Biotech(R) Inc.'s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference
Date:5/14/2009

CALGARY, May 14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) announced today that data from three clinical trials using REOLYSIN are scheduled to be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting will take place in Orlando, Florida May 29-June 2, 2009. The abstracts are available on the ASCO website today at www.asco.org.

    REOLYSIN poster presentations

    -   Dr. Monica Mita and colleagues are scheduled to deliver a poster
        presentation entitled "A Phase II Study of Intravenous (IV) Wild-Type
        Reovirus in the Treatment of Patients with Bone and Soft Tissue
        Sarcomas Metastatic to the Lung."

    -   Dr. Johann de Bono and colleagues are scheduled to deliver a poster
        presentation entitled "A Phase I Study of the Combination of
        Intravenous Reolysin (REO) and Gemcitabine (GEM) in Patients (pts)
        with Advanced Cancer."

    -   Dr. Sanjay Goel and colleagues are scheduled to deliver a poster
        entitled "Dose Escalation and Pharmacodynamic Study of Intravenous
        Administration of REOLYSIN, a Live Replication Competent RNA Virus in
        Patients with Advanced Solid Tumors."

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN, its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit www.oncolyticsbiotech.com

T
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...1 /PRNewswire-Asia/ -- Shanghai ChemPartner, as th...ina-based Contract Research,Organization (CRO), to...Technology Fast 50 China, ranking 3rd on the list ...a. The award is a testament to ChemPartner,s outst.... , The results of the 2009 Deloitte Tech...
(Date:12/1/2009)...1 The Burrill Biotech Select Index...t in October. The Select,s gain of 4.5 percent mir...eral markets with the Dow up 6.5 percent and the N... in the final two trading days of the month despit...iday shopping and Dubai,s reported debt woes. ,...
(Date:12/1/2009)...ent Software agrees to migrate their Microsoft Dyn...ents) to Synergy Business Solutions to maintain qu... WA (PRWEB) December 1, 2009 -- Synergy Business S...soft Dynamics SL practice of Congruent Software, a...ve was necessary due to a change in Congruent Soft...
(Date:12/1/2009)...BEACH, California and AMSTERDAM, December 1 /PRNew...cer diagnostics, announced today that,Palmetto GBA...established,coding guidelines for the company,s Ma... breast cancer recurrence test, which has been rei...across the United States can now submit claims for...
Breaking Biology Technology:Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2
...arch conducted at The,Walter and Eliza Hall Instit...r licensing agreement signed between Australian bi...ny-based pharmaceutical company, Merck,Serono., U...k Serono will seek,to develop new treatments for m...ions. These prospective treatments will be based u...
...) Adult cells of mice created from genetically re... (IPS) stem cellscan be triggered via drug to ente...eed for further genetic alteration. , The discove...bryonic stem cell research, is reported in the Jul... , "This technical advancement will allow thousan...
...ly established Small Interfering Ribonucleic Acid ...as been charged with providing high-quality siRNA ...customers. , HOUSTON (Bu...as chosen Stone Bond Technologies, EE-LIMS™ ...low at its siRNA facility, increasing throughput, ...
Other Biology Technology:MS Drug Development Agreement Based on WEHI's Medicinal Chemistry 2New technique produces genetically identical stem cells 2 M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies : EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks 2
(Date:11/30/2009)...Health Sciences Center New Orleans School of Publi...e of Child Health and Human Development (NICHD), H...s Hospital, and Harvard Medical School, have found...ings of sugar- sweetened cola a week prior to preg... developing diabetes during pregnancy. Liwei Chen,...
(Date:11/30/2009)...Conference on Systems & Enterprises (GCSE), to be ...s on the convergence of complex large-scale system...y. , The goal of the conference is to build ...omplex systems, examined by domain, each successiv...structure Systems, including Intelligent/Smart Inf...
(Date:11/30/2009)...istration rates and register online now for the pr...w.iofwco-ecceo10.org/ , WHAT: IOF WCO-ECCEO10 ...sis Foundation (IOF) and the European Society for ...Osteoarthritis (ESCEO). More than 5,000 participan...he exciting scientific programme includes 12 plena...
Breaking Biology News(10 mins):Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Small mechanical forces have big impact on embryonic stem cells 10410 1Small mechanical forces have big impact on embryonic stem cells 10410 2A major step in making better stem cells from adult tissue 10407 1A major step in making better stem cells from adult tissue 10407 2A major step in making better stem cells from adult tissue 10407 3A major step in making better stem cells from adult tissue 10407 4Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 1Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 2Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 3
...ar neighborhood to a friend,s house or deciding on...pting. It can make decisions based on incomplete i... information. , The nature of such sophisticated d...sponsible for high-level processing, has been "poo...ako Yoshida and Shin Ishii of the Nara Institute o...
... antioxidants is recognised as one way of helping ...levels. , The herbal medicine extracted from seed...) is known to have antioxidant properties and rese...shows that this extract can help people significan... in blood, as well as reducing fasting blood sugar...
...rm of good cholesterol provides significantly bett... therapy using the "normal" HDL gene, according to... at Cedars-Sinai Medical Center and reported in th...ege of Cardiology. , Apolipoprotein A-I is a natu...ity lipoprotein), the "good" cholesterol that circ...
Other Biology News:Where we change our mind 2Gene transfer using mutant form of good cholesterol cuts vascular plaque and inflammation 2Gene transfer using mutant form of good cholesterol cuts vascular plaque and inflammation 3
... activity is expressed in g per ml and is determin...ine, pH 6.8, of a 1 mg per ml solution. This act... 2% suspension of human blood group A erythrocytes...te: Affinity purified by a modification of the met...
Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
File Holder from Terra Universal, Inc.
...ome-wide microRNA expression profiling and built o...n-chip synthesis platform. These microarrays are a...ression Profiling Service. Probe Content The So... soil nematode microRNAs (114 unique mature sequen...
Biology Products: